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CHAPTER I 
INTRODUCTION 
 Retrospective self report data is often used for a wide range of research 
purposes, and is especially prominent in the behavioral and medical fields.  This 
method of self report has been particularly useful in research of the illness 
commonly referred to as myalgic encephalomyelitis/chronic fatigue syndrome 
(ME/CFS). The precise definition of ME/CFS is often debated, but the most 
widely used case definition stipulates that to meet criteria for the illness, a person 
must have experienced six or more months of chronic fatigue of new or definite 
onset, that is not substantially alleviated by rest, not the result of ongoing 
exertion, and that results in substantial reductions in occupational, social, and 
personal activities (Fukuda, et al., 1994). Furthermore, a person must have four 
out of eight accompanying symptoms (e.g. sore throat, lymph node pain, muscle 
pain, joint pain, post-exertional malaise, headaches of a new or different type, 
memory and concentration difficulties, and unrefreshing sleep) that have also 
persisted for at least six months or longer (Fukuda et al., 1994). Retrospective self 
report methods are often used in research settings to determine whether an 
individual has experienced the required fatigue and accompanying symptoms for 
the length, frequency, and severity necessary to receive a diagnosis of ME/CFS 
(Hawk et al.,  2007; Jason et al., 1999; King & Jason, 2005; Reeves et al., 2005).  
 More generally, self report data can help researchers and health care 
personnel gain information about the health status and quality of life of 
individuals suffering from various health problems, medical conditions and 
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chronic illnesses. Retrospective data have proved to be very useful because it is 
less costly and time intensive than prospective, longitudinal studies and allows 
researchers and health professionals to gather information about events that may 
have occurred weeks, months, or years prior to participation in a research study or 
formal health evaluation (Beckett, Da Vanzo, Sastry, Panis, & Peterson, 2001).  
Although there is clear utility in using retrospective self report data to assess 
health status, retrospective surveys (no matter how simple the question) often 
require complex mental processes. For instance, when a respondent is confronted 
with a question that asks about a past event, he/she implicitly goes into a series of 
steps in order to recall the information. The respondent must process and interpret 
the question, evaluate the question in terms of his/her individual knowledge and 
the general scope of the survey, understand the interviewer or administrator‟s 
expectations, and evaluate the response in terms of its social desirability 
(Bradburn, Rips, & Shevell, 1987).  
 Research on these psychological processes and their potential effects on 
the validity and reliability of survey data suggest that researchers need to be 
careful when designing and evaluating studies that involve retrospective methods 
for gathering information. Specifically these processes can contribute to the 
phenomenon known as recall bias, which occurs when the ability to accurately 
and reliably report an event is dependent on the strength of the memory for the 
event as well as environmental factors. For instance, if a person‟s memory for a 
specific event is distorted in any way, it will be more difficult to accurately report 
the event when asked to on a survey. 
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  It is particularly important to assess the phenomenon of recall bias for 
health symptoms because the more a physician knows about a patient‟s 
symptoms, the more information they have when developing effective treatment 
plans. Furthermore, controlling for recall bias is especially important in the 
assessment of symptoms experienced by individuals with ME/CFS. Currently, 
ME/CFS is a poorly understood illness without any universally recognized 
biological markers. Therefore, self-report measures are heavily relied on for 
making diagnostic decisions. This reliance on patient report data allows for biases 
that may ultimately decrease the reliability and validity of diagnostic assessments. 
Furthermore, many measures used to assess health symptoms have varying 
reporting periods (recall timeframes) and although research has found that recall 
bias may increase with longer reporting periods, few studies have been conducted 
in this area (Broderick et al., 2008). It may be especially important to understand 
how varying reporting periods are more or less susceptible to recall bias when 
assessing symptoms of ME/CFS. Many researchers are hopeful that an 
improvement in the methods to diagnose the illness will lead to a more 
homogenous illness group which in turn would make it easier for scientists to find 
clear biological markers of the disease (Jason et al., 2010). 
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Recall Bias: A General Overview 
  Specific biases that can occur in retrospective data include either 
forgetting that an event ever occurred and thereby not reporting it on a survey 
(omission), or misremembering an event as having occurred more recently in time 
than it actually did (telescoping) (Sudman & Bradburn, 1973). Whether these 
biases occur depends on a variety of factors that have to do with the 
characteristics of the event, the way in which an individual perceives the event, 
and the context in which an event is remembered (Stull, Leidy, Parasuraman, & 
Chassany, 2009). Characteristics related to the event itself might include how 
recent in time the event occurred in relation to the evaluation or assessment 
(recency) as well as the complexity for the event in question. Furthermore, the 
personal significance of an event (saliency) (Gendreau, Hufford, & Stone, 2003), 
as well as the respondent‟s mood at the time an event is remembered (Stull, 
Leidy, Parasuraman & Chassany, 2009), may also impact an individual‟s memory 
for it. The degree to which certain factors will affect a person‟s memory for past 
events, as well as the circumstances in which these factors are most influential, 
are important for researchers to understand when designing and evaluating 
research studies.  
Timeframe and Recall Bias 
   Much of the current research on cognitive theory and recall bias has been 
influenced by the early work of Ebbinghaus in 1885 and his influential “forgetting 
curve.” Ebbinghaus famously demonstrated that the rate at which individuals 
forget information is more pronounced immediately after an event has occurred, 
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and that the degree of forgetting tends to plateau as more time goes by 
(Ebbinghaus, 1913). This early work by Ebbinghaus has influenced more recent 
studies looking at how the recency phenomenon influences our ability to 
accurately remember events. Studies have shown that the longer the recall period, 
the less accurate a person‟s memory is for distinctive and autobiographical events 
(Bradburn et al.,  1987; Skowronski, Betz, Thompson, & Shannon, 1991).  
Furthermore, longer recall periods reduce response accuracy for hospitalizations, 
health events, symptom onset, and overall morbidity (Amjadi-Begvand et al., 
2004; Celebrezze & Terry, 1965; Dedominicis & Grechi, 1965; Feikin et al., 
2010).  Other studies, however, have found that longer recall periods do not 
necessarily result in decreased accuracy or reliability. For instance, it has been 
found that people can consistently report pain severity (Brauer, Thomsen, Loft, & 
Mikkelson, 2003) as well as missed workdays (Rivicki, Irwin, Reblando, & 
Simon, 1994) at one month and three month reporting periods. Additionally, it has 
also been found that the Positive Affect-Negative Affect Scale (PANAS), has 
excellent test-retest reliability across multiple timeframes (e.g. current, today, past 
few days, past week, past few weeks, past year, general) (Watson, Clark, & 
Tellegen, 1988; Watson & Clark, 1994).  
 Overall, more support has been garnered for greater inaccuracies as recall 
period is increased, which might suggest that retrospective surveys should include 
very short reporting periods. On the other hand, shorter reporting periods are not 
without biases either. For instance, the phenomenon known as forward 
telescoping happens more often with shorter reporting periods such as asking 
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someone to recall information over the past week (Bradburn, 2000). Forward 
telescoping occurs when a person reports events that occurred prior to the 
reporting period designated on a survey item, and this in turn causes an 
overreporting of events (Bradburn, 2000; Sudman & Bradburn, 1973). Biases 
associated with longer reporting periods (e.g. the past six months; the past year) 
are more likely to involve the phenomenon of forgetting, which in turn causes 
omission of information and overall underreporting of events (Clarke, Fiebig, 
Gerdtham, 2008; Sudman & Bradburn, 1973).  
 Some studies have found that an underreporting of events is more 
common than overreporting. This phenomenon has been particularly recorded for 
reports of health care utilization (Evans & Crawford, 1999). It has been suggested 
that these over and underreporting biases may cancel each other out as long as the 
optimal reporting period is utilized on a survey. This optimal reporting period 
may be a timeframe that falls in between the extremely recent and very long 
(Sudman & Bradburn, 1973), but it is still unclear how one decides what reporting 
period is too long or too short. This issue may depend on other factors that have 
been shown to influence our memory for past events (e.g. complexity, saliency, 
and mood). 
Recall Bias: Stability, Complexity, and Context 
 In addition to his research on the phenomenon of recency, Ebbinghaus 
also discovered that the rate of forgetting depends on the characteristics of the 
event or phenomena in question (Stull et al., 2009).  For instance, events that are 
fairly stable over time or those that happen once in a lifetime are remembered 
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with greater ease than events that change and fluctuate over time (Stone & 
Shiffman, 2002).  When choosing what timeframe to use in a survey, it is 
important to know as much about the phenomenon being measured as possible. 
For instance, a short recall period may enhance information accessibility for the 
specific time period, but if there is no stable pattern to the phenomena, a short 
recall period might not capture the true nature of the symptom‟s variability over 
time (Stone & Shiffman, 2002; Stull et al., 2009). Clarke et al. (2008) assert that 
there is a tradeoff between reporting accuracy and loss of information when 
deciding between a shorter or longer recall timeframe. Short timeframes may 
increase the accuracy of recall, but investigators risk losing valuable information 
about the true nature of the phenomena that would be better captured with a 
longer recall period. In other words, a short timeframe is not always compelling 
for certain phenomena and it is important to take variability and stability into 
account when thinking about an optimal timeframe (Clark et al. 2008).  
 In the case of health symptoms, Stone and colleagues (2002) assert that 
when someone reports about a highly variable symptom, they are making an 
overall assessment of their experience, but cannot indicate the variable nature of 
the symptom in such a short time period. However, when highly variable 
symptoms are reported over longer timeframes, an individual will attempt to 
summarize their experience, which can reduce reporting accuracy (Stone, 
Schwartz, Broderick, & Shiffman, 2005). The complexity of recalled information 
has been described by Converse and Presser (1986) and later by Reis and Gable 
(2000) as information accessibility (as cited in Stull et al., 2009). Certain 
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phenomena are accessed with greater ease than others. For instance the names of 
medications are less accurately recalled compared to a person‟s memory for 
hospitalization utilization (Evans & Crawford, 1999).  Additionally, medical 
conditions are harder to recall if a survey includes scientific terms used by 
physicians rather than using more layman‟s terms for conditions (Madow, 1967); 
a finding that highlights the importance of thoughtful planning for constructing 
clear and culturally sensitive surveys.  
 Context can also have a profound effect on response bias. Context related 
to recalled information refers to the personal and social meaning the information 
has for the respondent, as well as how this information is perceived in the broader 
environment (Stull et al., 2009).  One specific contextual factor that can affect 
recall accuracy is the saliency of the information being recalled. The saliency of a 
recalled event has to do with its significance or personal relevance to the 
respondent. In terms of recall bias, highly salient information is often recalled 
more accurately than less salient information. This finding has been reported for 
recall of major symptoms versus minor symptoms (Cannell, Marquis, & Laurent, 
1977), for recall of pain intensity versus pain location (Dawson, Kanim, & Sra, 
2002), and for recall of information when in in-patient hospitalization versus out-
patient consultation (Stull et al., 2009).  
 Another factor affecting recall is the mood and health status of the 
respondent at the time of an assessment or evaluation (Broderick, Schwartz, 
Shiffman, Hufford,  & Stone, 2003).  Specifically, when people are in a negative 
mood, they are more likely to access and recall information that is also negatively 
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charged (Stull et al., 2009). This phenomenon of current mood bias is seen with 
recall of affect and attitude (Blaney, 1986) as well as in medical research. For 
instance, someone who is experiencing more pain during an assessment is more 
likely to recall past pain symptoms as more severe than they had initially reported 
at baseline (Eich et al., 1985).  
Recall for Health Symptoms 
 Retrospective survey data is used in many different areas of study, but in 
order to assess the accuracy and reliability of this type of data in the context of an 
illness such as ME/CFS, it is important to understand recall bias that is associated 
with specific health symptoms. Two symptoms that are commonly cited in the 
recall literature and that are frequently experienced by individuals with ME/CFS 
are pain and fatigue.  
 Pain has been studied under a variety of different contexts, including 
rheumatoid arthritis (Stone, Broderick, Kaell, DelesPaul, & Porter 2000; 
Broderick et al., 2008), chronic pain (Stone, Broderick, Shiffman, Litcher-Kelly, 
& Calvanese, 2003; Stone et al., 2005), and the illness known as fibromyalgia 
(Williams et al., 2004). In order to compare recalled pain with averaged 
momentary pain assessments, researchers have used paper daily diaries, electronic 
diaries, ecological momentary assessment (EMA) techniques, and a combination 
of prospective and retrospective survey methods (McColl, 2004; Stull et al., 
2009).  Within this literature, researchers have consistently found that there is a 
tendency to recall higher pain levels than were previously reported at baseline. 
Stone, Broderick, Shiffman, and Schwartz (2004) suggest that the discrepancy 
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between recalled pain and momentary pain may be due to the tendency to only 
recall salient pain events and to ignore periods where pain is not experienced as 
intensely. Specifically, it has been shown that when attempting to make an overall 
pain assessment, patients are not merely averaging their pain; rather, they are 
using cognitive heuristics in which they rely on aspects such as the variability of 
the pain experience (Redelmeier, Katz, & Kahneman, 2003), peak periods of pain 
over time (Stone et al., 2000), the most recent pain experiences (recency) 
(Redelmeier et al, 2003; Stone et al., 2000), and/or a combination of peak and 
recency known as “peak-end” (Kahneman, Fredrickson, Schreiber, & Redelmeier, 
1993; Redelmeier, & Kahneman, 1996).  Despite the discrepancy between 
recalled pain and momentary pain, there is still a moderate correlation between 
the two reporting periods and this moderate correlation might suggest to 
researchers that either method is sufficient for assessing pain.  However, when 
changes in recalled pain and momentary pain are compared in a “within subjects” 
design, the correlation is significantly lower (Stone et al., 2004). Furthermore, it 
has been found that people with chronic pain who perceived their pain as 
worsening over time, did not show a significant change in multiple reports of 
momentary pain assessments (Stone et al., 2004).  
 Research on pain across different reporting periods suggests that when 
patients are asked to recall pain, their recall accuracy weakens over the course of 
seven days. However it was also found that correlations between recalled pain 
ratings and momentary pain ratings were higher for a 28 day recall timeframe 
compared to a seven day recall timeframe (Broderick et al., 2008).  Broderick and 
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colleagues (2008) theorize that individuals with chronic illnesses may have a 
good idea of their typical symptom pattern overtime, thus allowing them to make 
an overall assessment of the last 28 days based on their symptom beliefs.  This 
explanation seems best to describe chronic symptoms that are fairly stable 
overtime, but it is still unclear if pain that is fluctuating over a long period of time 
would have a similar effect on recall. Beyond issues related to accuracy and 
reporting length, Williams, Davies, and Chadury (2000) found that chronic pain 
patients may not always be recalling pain severity, but may instead report on the 
perceived impact that the pain has on functioning. Additionally, they found that 
the way one respondent interprets a pain rating scale can be very different from 
the way another person will (Williams et al., 2000).  These results underscore the 
subjective nature of pain as well as its multidimensionality.  
 A handful of studies have investigated issues of recall for chronic fatigue 
and fatigue related to the illness ME/CFS (Broderick et al., 2008; Friedberg & 
Sohl, 2008; Sohl & Friedberg, 2008). Similar to findings within the pain 
literature, participants report experiencing higher levels of fatigue when it is 
recalled retrospectively compared to multiple momentary fatigue assessments. 
Despite this discrepancy, there is still a moderate to high correlation between a 
person‟s retrospective rating of fatigue and the average of their momentary ratings 
of fatigue (Broderick et al., 2008; Friedberg & Sohl, 2008). It has also been found 
that the more variable the fatigue, the higher the discrepancy between recalled 
fatigue and averaged momentary fatigue (Sohl & Friedberg, 2008); further 
validating the proposed impact of symptom stability on recall accuracy. 
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  Much of the literature on recall bias for health related symptoms focuses 
on general pain and fatigue.  Only a couple of studies have assessed recall 
accuracy for these symptoms in the context of the illness ME/CFS (Friedberg & 
Sohl, 2008; Sohl & Friedberg, 2008). Furthermore, the authors of these studies 
limited their investigation to the extent that retrospective recall correlates with 
momentary recall (i.e. recall accuracy). The diagnostic measures used in research 
can only be useful if they are shown to be both accurate and reliable (Spitzer, 
Endicott, & Robins 1978); therefore, it is equally important to evaluate the effects 
of varying timeframes on the reliability of recall for health symptoms.  
Reliability of ME/CFS Symptom Ratings 
 A few studies have evaluated the test-retest reliability of specific 
diagnostic instruments used in ME/CFS research (Hawk et al., 2007; Jason et 
al.,1997).  For instance, Hawk et al. (2007) investigated the issue of diagnostic 
reliability and test-retest reliability of a CFS Questionnaire. The CFS 
Questionnaire is a revised version of the CFS Screening Questionnaire developed 
by Jason et al. (1997) and can be used as a diagnostic instrument based on the 
Fukuda et al. (1994) criteria. In order to determine the sensitivity, specificity, and 
reliability of the measure, Hawk and colleagues (2007) administered the measure 
at two time points and to individuals with ME/CFS, major depressive disorder 
(MDD), and to healthy controls. Items from the CFS Questionnaire assess aspects 
of functioning and symptom experience and incorporate varying timeframes that 
range from „the past day‟ to the „past six months.‟ Participants completed the CFS 
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Questionnaire twice with two weeks in between each assessment and independent 
raters evaluated each assessment to determine a diagnosis.  
 Based on evaluations from the independent raters, the researchers found 
that the average test-retest reliability of the measure was very good, with most 
intraclass correlation coefficients at .70 or higher; however, different items were 
found to have better reliability scores than others.  For instance, some items on the 
CFS questionnaire were developed to assess the reported frequency and severity 
of the eight ME/CFS case defining symptoms (fatigue/sickness following mental 
or physical exertion, unrefreshing sleep, problems remembering or concentrating, 
muscle aches and pains, joint pain, sore throat, tender lymph nodes/swollen 
glands, and headaches) recalled over the past six months. Overall, the average 
intraclass correlation scores for these items were very good (.77); however two 
symptoms (tender/sore lymph nodes and pain in multiple joints) had somewhat 
lower reliability scores (.58 and .49  respectively) (Hawk et al., 2007). Some 
additional items also had lower test-retest reliability scores. For instance, items 
asking participants to rate (on a scale of 0 to 100) their perceived energy, amount 
of expended energy, and amount of fatigue experienced over the past 24 hours, 
had lower reliability scores (.59, .40, and .22 respectively). Interestingly, these 
same items were also recalled at a slightly longer timeframe (over the past week) 
and resulted in better reliability scores (.77, .59, and .81 respectively). The authors 
have suggested that these symptoms likely fluctuate often and can be more 
consistently recalled over a longer timeframe. Furthermore, these results suggest 
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that it is important to take into account the type of question being asked and the 
timeframe in which it is asked when developing reliable diagnostic instruments.     
 The most widely used case definition for ME/CFS (Fukuda et al., 1994) 
requires a person to have at least six months of disabling fatigue and also four out 
of eight core symptoms (impaired memory or concentration, headaches, sore 
throat, lymph node pain, muscle pain, joint pain, unrefreshing sleep, and post-
exertional malaise) also lasting six months or longer (Fukuda et al., 1994).  This 
definition has been criticized for being too vague and lacking objective criteria to 
reliably classify individuals with ME/CFS (Jason et al., 2010). In order to 
improve the objectivity and reliability of the diagnostic criteria, researchers have 
recommended the use of standardized measures for charting and assessing 
symptoms of ME/CFS (King & Jason, 2005).   
 The Centers for Disease Control and Prevention (CDC) has developed an 
empirical case definition that assesses fatigue, the eight accompanying symptoms 
of ME/CFS, and disability, using validated and standardized measures (Reeves et 
al., 2005). The authors of the empirical case definition use the Symptom 
Inventory (Wagner et al., 2005) to assess the occurrence, frequency, and severity 
of the eight accompanying symptoms of ME/CFS recalled over the past month. 
The Medical Outcomes Survey Short-Form-36 (SF-36) is used to assess 
disability, and utilizes either a four-week recall timeframe or a one-week recall 
timeframe (Keller et al., 1997). Lastly, the Multidimensional Fatigue Inventory 
(MFI) is used to assess fatigue and requires participants to rate symptoms over the 
previous days (Smets, Garssen, Bonke, & Haes, 1995).   
15 
 
 Each standardized measure included in the empirical case definition 
employs different timeframes, and this is not uncommon in many research 
studies. Some instruments used in research of health symptoms use multiple recall 
timeframes on a single questionnaire and others do not even specify a timeframe 
(Broderick et al., 2008). Furthermore, there is rarely any justification given for 
why a particular timeframe is used (Broderick et al., 2008). Given, the strong 
need for objective and reproducible ME/CFS criteria, it would be beneficial to 
determine the degree to which varying timeframes impact recall for specific 
ME/CFS symptoms.  
 The empirical case definition has received considerable controversy, as 
some have found that the definition may erroneously include people with primary 
psychiatric conditions and may lack the appropriate sensitivity for selecting 
individuals with the illness (Jason, Najar, Porter, & Reh, 2009; Jason et al., 2010). 
Although the empirical case definition may not become the staple of diagnosis 
and assessment in ME/CFS research, many future efforts will likely be made to 
establish an empirically derived case definition to improve the accuracy and 
reliability of diagnoses; especially in the absence of unequivocal biological 
markers. 
  Overall, researchers in the field have recommended that measures used to 
chart and assess symptoms of ME/CFS be both comprehensive and sensitive to 
the variability of symptom experience across individuals with this illness (Jason et 
al., 1999). Also, it has been noted that differences in the criteria used to classify 
individuals with ME/CFS accounts for the largest proportion of diagnostic 
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unreliability (Jason, Helgerson, Torres-Harding, Carrico, & Taylor, 2003). In 
order to decrease criterion variance and enhance diagnostic reliability, researchers 
have suggested that ME/CFS criteria incorporate specific standardized 
instruments to use as well as explicit guidelines regarding the  number, frequency, 
and severity of symptoms required for a diagnosis.  In light of these issues as well 
as the extensive reliance on self-report measures in ME/CFS research, the impact 
of different recall timeframes should also be investigated when developing and 
evaluating the diagnostic criteria for ME/CFS. Furthermore, it has been argued 
that the validity and reliability of symptom recall is important for developing 
appropriate treatments (Fienberg, Loftus, & Tanur, 1985). More research needs to 
be done to determine the optimal recall length for assessing specific symptoms of 
ME/CFS.  
In sum, retrospective self-report measures are often used in research to 
assess symptoms that are commonly reported by individuals with ME/CFS. This 
reliance on patient report data allows for biases that may negatively impact the 
reliability and validity of diagnostic and treatment decisions. Furthermore, many 
measures used to assess ME/CFS symptoms have varying recall timeframes. It is 
unclear what the optimal reporting period is for tracking health symptoms, 
especially for a complex chronic illness such as ME/CFS where certain symptoms 
may fluctuate overtime. Only a small number of studies have investigated the 
issue of recall bias for symptoms of ME/CFS, and these studies limited their 
investigation to the extent of agreement between patients‟ reports of momentary 
fatigue versus fatigue that was recalled over a week-long timeframe (Friedberg & 
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Sohl, 2008; Sohl & Friedberg, 2008). There are a few documented studies that 
have assessed the test-retest reliability of an ME/CFS diagnostic instrument that 
includes multiple timeframes for different items; however, to this authors‟ 
knowledge there are no reported studies in the ME/CFS literature that have 
assessed the test-retest reliability of each case-defining symptom on a 
standardized instrument across varying timeframes. For instance, Hawk, et al. 
(2007) assessed test-retest reliability for the eight case-defining symptoms of 
ME/CFS recalled over a six month timeframe; however, it is unclear whether test-
rest reliability would be stronger for these symptoms at shorter timeframes.  
 The ME/CFS literature is lacking information on the potential impact of 
timeframe on symptom recall in individuals with ME/CFS. In response to this 
lack of important psychometric information, this study served as an evaluation of 
the test-retest reliability of a revised Symptom Inventory that includes four 
different timeframes (right now, past week, past month, and past six months).  
Research has shown that both short (e.g. past week) and long recall periods (e.g. 
past six months) can negatively impact recall accuracy for health symptoms in 
different ways. Furthermore, contextual factors such as symptom stability and 
momentary symptom severity have also been found to impact reporting accuracy. 
Very little research has been done on the ways varying timeframes and contextual 
factors can influence the test-retest reliability of health symptom reports; 
particularly in the context of ME/CFS.  
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Statement of Hypotheses and Research Questions 
Hypothesis I. ME/CFS symptoms will be recalled with greater consistency (yield 
stronger reliability coefficients) when symptoms are perceived as stable over time 
rather than variable. 
Hypothesis II. An increase in momentary (right now) symptom severity ratings 
from baseline to assessment two (occurring one week later) will significantly 
predict an increase in past week, past month, and past six month symptom ratings 
from baseline to assessment two. A decrease in momentary (right now) symptom 
severity ratings from baseline to assessment two (occurring one week later) will 
significantly predict a decrease in past week, past month, and past six month 
symptom scores from baseline to assessment two.  
Research Question Ia. Is there an optimal recall timeframe in terms of test-retest 
reliability, for ME/CFS symptoms that are perceived as variable over time? 
Supplemental Research Question 1b. Is there an optimal recall timeframe in terms 
of test-retest reliability, for ME/CFS symptoms that are perceived as stable over 
time? 
Research Question II. Does the optimal recall timeframe in terms of test-retest 
reliability, differ by the ME/CFS symptom being measured? 
Research Question III. What is the optimal recall timeframe in terms of test-retest 
reliability, for ME/CFS symptoms, in the absence of contextual factors (e.g. 
symptom stability and momentary symptom severity)? 
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CHAPTER II 
METHOD 
This section presents information on participant recruitment, study 
procedures, and measurement tools. Data were collected over the phone at two 
time points, from individuals with a current diagnosis of ME/CFS. 
Participants 
 The study population consisted of 51 adults (45 women and 6 men), 
between the ages of 29 and 66 (M= 50.39) with a current diagnosis of ME/CFS.  
The majority of participants identified as White (94%), one participant identified 
as Asian/Pacific Islander, and two identified as “other.”  Two participants 
identified as Latin/Hispanic origin. Approximately half of all participants were 
married (N=27), 13 were never married, and 11 were divorced.  The majority of 
participants received a standard college degree or higher (70.6 %) and all 51 
participants reported at least a high school degree. Over half of the participants 
were on disability (58.8 %), with the large majority citing chronic fatigue 
syndrome as the cited reason for their disability claim. Only one participant 
reported working full-time and six reported working part-time. A large proportion 
of participant diagnoses (78%) were confirmed with letters of documentation by 
independent physicians. All 51 participants met criteria for the Fukuda et al. 
(1994) case definition.  Participants were identified through the use of an IRB 
approved research advertisement published in an ME/CFS Chicago newsletter. 
The current study group was also made up of individuals who participated in an 
earlier non-pharmacological intervention at DePaul University‟s Center for 
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Community Research (Brown & Jason, 2007).  Participants received a five dollar 
Amazon gift card upon completion of the study. 
Procedure 
  Data collection occurred on two separate occasions with one week 
between the first and second assessment. Researchers received verbal consent 
from participants over the phone and scheduled two phone interviews.  In order to 
ensure that all participants completed the questionnaires under the same 
conditions, the interviews took place over the phone and were scheduled with one 
week in between the first and second interview, at the same time and on the same 
day of the week.  During the first interview, participants were not told that they 
would be asked the same questions a week later, and instead were informed that 
they would be taking  another short symptom survey during the second interview. 
This was to ensure that participant responses at the second interview were not 
primed by the first.   
 During the first phone interview, participants were read questions aloud 
from a revised Symptom Inventory (SI-R: See Appendix A) which was altered by 
this author from the original Symptom Inventory developed by Wagner et al. 
(2005). Participants were also read a Symptom Stability Survey (See Appendix 
B), a short demographic survey, and a significant events questionnaire, all 
developed by this author and others at DePaul University. Phone interviewers 
repeated items for participants as necessary. During the second phone assessment, 
participants were read items from the SI-R, the Symptom Stability Survey, and 
the significant events questionnaire a second time. Following completion of the 
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second phone assessment, participants were debriefed on the purposes of the 
study. 
Measures 
  All study measures were administered over the phone by IRB approved 
graduate students and staff members at the Center for Community Research at 
DePaul University. Interviewers read the same set of instructions to all 
participants and recorded responses as they were given.  
ME/CFS Symptom Assessment 
  The Symptom Inventory-Revised (SI-R) (see Appendix A) assesses the 
presence, frequency and severity of the case-defining symptoms of ME/CFS 
(post-exertional malaise, unrefreshing sleep, problems with memory and/or 
concentration, muscle aches and pains, joint pain, sore throat, tender lymph 
nodes/swollen glands, and headaches) according to Fukuda et al. (1994). The SI-R 
is a revision of an earlier Symptom Inventory that was developed by the Center 
for Disease Control and Prevention (CDC). The CDC‟s symptom inventory 
assesses the frequency and severity of symptoms over the past month and has 
been shown to have good internal consistency, with a Chronbach‟s alpha 
coefficient  of 0.88 for the total  inventory score and 0.87 for the total score from 
a short-form version, including only six symptoms (fatigue after exertion, 
unrefreshing sleep, muscle aches, sleeping problems, problems with memory, and 
problems with concentration).  The CDC Symptom Inventory has also been found 
to have excellent convergent validity with standardized measures of fatigue and 
functioning (Wagner et al., 2005). For the purposes of this study, revisions to the 
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Symptom Inventory included the addition of four timeframes: right now, past 
week, past month, past six months. Additionally, participants‟ frequency and 
severity ratings on the SI-R were multiplied to create a composite score  for each 
symptom at the past week, past month, and past six month intervals, with scores 
ranging from 0 to 25 (Wagner et al., 2005). The momentary (right now) recall 
timeframe does not measure frequency; therefore, a composite score could not be 
created and instead, the right now timeframe served as a moderating variable in 
the analysis of hypothesis II. There is currently no information on the test-retest 
reliability of the CDC Symptom Inventory (Wagner et al., 2005) or on the 
unpublished revised version (SI-R) altered by this author for the purposes of the 
present study.  The CFS Questionnaire, developed by Hawk et al. (2007) also 
measures the Fukuda et al. (1994) case-defining symptoms using a six month 
timeframe, and these items were found to have very good test-retest reliability, 
with an average intraclass correlation score  of .77 across all  eight case-defining 
symptoms (Hawke et al., 2007).  
Symptom Stability 
 The Symptom Stability Survey (see Appendix B) was administered to 
participants at both phone assessments and is a measure of the perceived stability 
of each case defining symptom. For each symptom listed on the Symptom 
Stability Survey, respondents  indicated whether they perceived each symptom to 
have been relatively stable, fluctuating/variable, or not present over the course of 
the past six months. The Symptom Stability Survey was developed by this author 
at DePaul University for the purposes of the current study and there is currently 
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no information available on the internal consistency or test-retest reliability of this 
measure. Future analyses will be conducted to obtain data on the psychometric 
properties of the Symptom Stability Survey as well as the revised Symptom 
Inventory (SI-R).     
Demographic Information 
 Participants were administered a short demographic survey during the 
first assessment and following completion of the SI-R and the Symptom Stability 
Survey. The demographic survey included eight questions which assessed age, 
gender, weight, height, race, marital status, occupational status, number of 
children, and highest grade level.  
Significant Events 
 At the end of each phone interview, participants were administered a 
significant events questionnaire which asked questions related to the typicality of 
participant mental and physical health over the week of the interview and whether 
any recent significant events occurred that might have impacted mental and 
physical health at the time of the interview. Responses to the significant events 
questionnaire were not taken into account for the analyses presented in this paper, 
but will be evaluated in future analyses of the presented study sample. 
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CHAPTER III 
   RESULTS 
 The current study is an investigation of the effects of recall timeframe, 
symptom stability, and momentary symptom severity on the reliability of 
ME/CFS symptom reports. The present study utilized a multilevel modeling 
(MLM) approach within a repeated measures design in order to assess the 
reliability of symptom reports across two interview assessments. In order to assess 
the reliability of symptom reports using an MLM approach, the slope coefficients 
were observed, and those coefficients observed to be closest to 1.0, represented 
more reliable symptom reporting. Additionally, MLM allows for the assessment 
of nested data; thus providing a way to quantify the extent to which slope 
coefficients vary as a function of symptom stability, changes in momentary (i.e. 
right now) symptom severity, and timeframe. Presented below are the re-stated 
hypotheses and research questions as well as subsequent MLM analyses and 
results.  
For hypothesis I, it was expected that ME/CFS symptom composite scores 
would be recalled with greater consistency (yield stronger reliability coefficients) 
across interview assessments, when symptoms were perceived as stable over time 
rather than variable. A multilevel statistical model was used to test hypothesis I.  
Level 1 of the model tested the extent that interview one symptom composite 
scores predicted interview two symptom composite scores (see Table 1 for 
descriptive information of all nine symptom composite scores across two waves 
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and the three timeframes).  Level 2 of the model tested whether the perceived 
stability of each symptom (dummy coded as 1= stable and 0 = variable) :  
(1) predicted the symptom composite scores at interview two, and (2) moderated 
the reliability between interview one and interview two (see Table 2 for 
descriptive information of the nine ME/CFS symptoms rated as variable; See 
Table 3 for descriptive information of the nine ME/CFS symptoms rated as 
stable).  The symptom scores at the three recall timeframes were not analyzed 
separately in the analysis but were grouped to represent a single variable referred 
to as Interview One Scores Collapsed Across Timeframe. Group mean centering 
was conducted for the Level 1 variables, so as to control for the influence of 
between-person variance on the slope coefficients. 
 
Level 1: y ij= b0 + b1 Interview One Scores Collapsed Across Timeframe ij + rij 
     Y= Symptom composite scores at all three timeframes, at interview two 
Level 2: b0i= γ00 +  γ01 Stability i + υi 
     b1i = γ10 + γ11 Stability i 
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Table 1   
Means and Standard Deviations of Symptom Composites on the SI-R at  
Interviews 1 and 2, N=51 
 
   
 
 
 
 
 
 
  Interview 1 Interview 2 
Symptom Timeframe M (SD) M (SD) 
Sore Throat Week 4.25 (5.03) 4.88 (6.14) 
 Month 4.24 (4.94) 4.10 (5.05) 
 Six Months 5.35 (6.07) 5.21 (6.06) 
Lymph Nodes Week 5.71 (6.04) 5.14 (5.92) 
 Month 5.53 (6.18) 4.76 (5.18) 
 Six Months 6.43 (6.86) 5.45 (5.75) 
Post Exertional Week 16.82 (4.93) 16.86 (4.81) 
Malaise (PEM) Month 17.00 (4.96) 16.53 (4.95) 
 Six Months 17.90 (5.69) 17.14 (5.10) 
Muscle Pain Week 12.00 (6.26) 11.00 (5.87) 
 Month 11.73 (6.89) 11.33 (6.07) 
 Six Months 12.18 (6.64) 11.35 (5.99) 
Joint Pain Week 8.94 (6.78) 9.35 (6.87) 
 Month 9.45 (7.16) 8.90 (6.26) 
 Six Months 9.63 (7.59) 9.24 (6.66) 
Unrefreshing Sleep Week 16.92 (6.00) 17.41 (6.34) 
 Month 16.25 (6.29) 15.82 (5.97) 
 Six Months 16.20 (7.27) 15.94 (6.65) 
Headaches Week 7.39 (6.53) 7.25 (6.26) 
 Month 7.37 (5.40) 6.76 (5.56) 
 Six Months 8.41 (6.57) 7.41(5.37) 
Memory Problems Week 10.47 (6.52) 10.12 (7.14) 
 Month 10.47 (6.44) 10.25 (6.66) 
 Six Months 10.90 (6.72) 10.76 (6.89) 
Difficulty Week 11.75 (5.88) 11.96 (6.75) 
Concentrating Month 11.86 (6.20) 11.84 (6.25) 
 Six Months 12.71 (6.30) 12.20 (6.39) 
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Table 2 
 
Means and Standard Deviations of Symptom Composites on the SI-R at  
Interviews 1 and 2 for Symptoms Rated as Variable 
 
  Interview 1 Interview 2 
Variable Symptoms Timeframe M (SD) M (SD) 
Sore Throats  n=30 n=30 
 Week 4.30 (4.20) 4.80 (5.01) 
 Month 4.10 (3.43) 4.33 (4.44) 
 Six months 5.10 (4.20) 5.40 (5.75) 
Lymph Nodes  n=23 n=23 
 Week 5.83 (4.56) 4.70 (4.26) 
 Month 5.43 (4.83) 5.04 (4.83) 
 Six months 6.17 (4.52) 5.22 (3.43) 
PEM  n=5 n=5 
 Week 12.00 (2.12) 13.60 (5.55) 
 Month 14.00 (6.36) 10.60 (3.71) 
 Six months 15.20 (7.79) 13.60 (3.05) 
Muscle Pain  n=20 n=20 
 Week 8.75 (4.66) 7.45(3.85) 
 Month 7.60 (4.92) 7.85 (3.91) 
 Six months 8.50 (4.76) 7.75 (4.04) 
Joint Pain  n=23 n=23 
 Week 7.30 (5.45) 7.26 (5.15) 
 Month 7.26 (5.15) 7.61 (5.79) 
 Six months 7.78 (5.66) 7.22 (4.60) 
Unrefreshing Sleep  n=10 n=10 
 Week 10.10 (5.92) 11.30 (6.53) 
 Month 9.70 (4.72) 10.00 (5.29) 
 Six months 7.50 (4.79) 7.70 (3.86) 
Headache  n=31 n=31 
 Week 6.19 (5.21) 6.68 (5.75) 
 Month 6.74 (5.11) 5.65 (4.05) 
 Six months 7.19 (5.94) 6.45 (3.80) 
Memory   n=19 n=19 
 Week 7.16 (5.27) 7.63 (7.27) 
 Month 6.5  (5.2) 7.32 (5.31) 
 Six months 7.95 (6.51) 7.37 (4.78) 
Concentration  n=16 n=16 
 Week 10.69 (5.92) 10.06 (5.73) 
 Month 10.13 (5.71) 9.81 (4.07) 
 Six months 9.81 (4.07) 10.75 (5.36) 
28 
 
Table 3 
 
Means and Standard Deviations of Symptom Composites on the  
SI-R at Interviews 1 and 2 for Symptoms Rated as Stable 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  Interview 1 Interview 2 
Stable Symptoms Timeframe M (SD) M (SD) 
Sore Throats  n=8 n=8 
 Week 10.88  (5.00) 12.38 (7.73) 
 Month 11.63  (5.45) 9.75 (5.83) 
 Six months 14.38  (7.01) 12.50 (4.41) 
Lymph Nodes  n=14 n=14 
 Week 11.14 (6.24) 10.57 (6.72) 
 Month 11.14 (6.41) 8.86 (6.01) 
 Six months 13.14 (7.43) 11.21 (6.42) 
PEM  n=46 n=46 
 Week 17.35 (4.87) 17.22 (4.65) 
 Month 17.33 (4.76) 17.17 (4.65) 
 Six months 18.20 (5.45) 17.52 (5.15) 
Muscle Pain  n=30 n=30 
 Week 14.57 (5.86) 13.73(5.39) 
 Month 14.87 (6.27) 14.03 (5.76) 
 Six months 15.03 (6.20) 14.10 (5.54) 
Joint Pain  n=22 n=22 
 Week 13.09 (5.89) 13.72 (6.23) 
 Month 13.95 (6.03) 12.91 (5.65) 
 Six months 14.18 (7.20) 13.73 (5.96) 
Sleep  n=41 n=41 
 Week 18.59 (4.76) 18.90 (5.39) 
 Month 17.85 (5.58) 17.24 (5.26) 
 Six months 18.32 (6.12) 17.95 (5.55) 
Headache  n=16 n=16 
 Week 11.56 (7.20) 9.94 (6.69) 
 Month 10.44 (4.41) 10.50 (6.48) 
 Six months 12.88 (5.49) 11.00 (6.21) 
Memory   n=31 n=31 
 Week 12.77 (6.28) 11.94 (6.58) 
 Month 13.16 (5.75) 12.35 (6.45) 
 Six months 12.94 (6.21) 13.13 (7.05) 
Concentration  n=35 n=35 
 Week 12.23 (5.88) 12.83 (7.08) 
 Month 12.66 (6.32) 12.77 (6.88) 
 Six months 13.60 (6.57) 13.17 (6.97) 
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Hypothesis I was supported for three of the eight case-defining ME/CFS 
symptoms: PEM, headaches, and memory problems. For post-exertional malaise, 
there was a significant main effect of symptom stability F (1, 49) = 5.93, p = .019; 
however, there was not a main effect of PEM composite scores at interview one, 
F (1, 100) = .087, p = .768, in predicting PEM composite scores at interview two. 
There was a significant interaction effect F(1, 100) = 4.16, p = .044, such that the 
relationship between PEM composite scores at the first interview and PEM 
composite scores at the second interview was significantly stronger for those who 
rated their symptoms as stable than for those who did not, b = 0.48, SE = 0.23, 
t(100) = 2.04, p = .044. The within variance of the distribution residuals was 6.98 
and the between variance of distribution residuals was 14.50.  The ICC score was 
calculated as .68, suggesting that 68 percent of the variance in predicting PEM 
scores at interview two is explained by the nesting of both individual factors and 
symptom stability. 
 For headaches, there was a significant main effect of symptom stability    
F(1, 45) = 9.62, p = .003, but not a main effect of memory composite scores at 
interview one F(1, 92) = 0.01, p = .931, in predicting headache composite scores 
at interview two. There was a significant interaction effect                                           
F(1, 92) =13.74, p < .001, such that the relationship between headache composite 
scores at interview one and headache composite scores at interview two was 
significantly stronger for those who rated their symptoms as stable than for those 
who did not, b = 0.66,  SE = 0.18, t(92) = 3.71, p <  .001. The within variance of 
the distribution residuals was 9.90 and the between variance of distribution 
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residuals was 16.24. The ICC score was calculated as .45, suggesting that 45 
percent of the variance in predicting headache scores at interview two is explained 
by the nesting of both individual factors and symptom stability. 
 For memory problems, there was a significant main effect of symptom 
stability F(1, 48) = 7.94, p = .008, but not a main effect of memory composite 
scores at interview one F(1, 98) = 0.91, p = .343, in predicting memory composite 
scores at interview two. There was a significant interaction effect F(1, 98) = 9.45 
p = .003, such that the relationship between memory composite scores at 
interview one and memory composite scores at interview two was significantly 
stronger for those who rated their symptoms as stable than for those who did not, 
b = 0.53, SE = 0.17, t(98) = 3.07, p = .003. The within variance of the distribution 
residuals was 5.32 and the between variance of distribution residuals was 35.84. 
The ICC score was calculated as .87, suggesting that 87 percent of the variance in 
predicting headache scores at interview two is explained by the nesting of 
individual factors and symptom stability.  
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 For Hypothesis II, it was expected that an increase in momentary (right 
now) symptom severity ratings from interview one to interview two would 
significantly predict an increase in past week, past month, and past six month 
symptom scores from interview one to interview two. A decrease in momentary 
(right now) symptom severity ratings from interview one to interview two will 
significantly predict a decrease in past week, past month, and past six month 
symptom scores from interview one to interview two (for a display of the means 
and standard deviations of the symptom severity scores at all four timeframes and 
across interviews one and two,  please refer to Table 7 under Appendix C). 
 A multilevel statistical model was used to test Hypothesis II. Level 1  of 
the model tested the extent that past week, past month, and past six month 
symptom composite scores (variable notation in the model is Timeframe) 
predicted symptom composite scores at interview two. Level 2 of the model tested 
whether the change (increase or decrease) in Right Now severity ratings over a 
one week interval predicted symptom composite scores (i.e. collapsed across 
timeframe) at interview two. In order to determine the change in momentary 
severity at each symptom from interview one to interview two, a Right now 
Difference Score (Right Now Diff.) was calculated (Right Now severity score at 
interview two minus Right Now severity score at Interview one). The model 
presented below was re-estimated changing the reference group for timeframe, in 
order to test the significance of the slope for each timeframe. Timeframe is a 
categorical variable that is dummy coded in the estimation of the model.  Two 
dummy vectors are used for each time that Timeframe appears in the model. 
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Level 1: y ij = b0 + b1 Timeframe ij + rij 
     y= Symptom composite scores at interview two 
Level 2: b0i= γ00 +  γ01 Right Now Diff. i 
        b1i= γ10 + γ11 Right now Diff. i  
Hypothesis II was supported for two of the case-defining ME/CFS symptoms, 
sore throats and difficulty concentrating, but only when the reference group was 
six months.  
Sore Throat 
  The right now difference score significantly predicted sore throat scores 
at interview two, when the reference group was the six month timeframe, b = 
4.21, SE = 1.86, t(22.09) = 2.26, p =.03, such that, an increase in the right now 
severity score from interview one to interview two, significantly predicted an 
increase in the sore throat composite score for interview two. The right now 
difference score does not significantly predict sore throat composite scores at 
interview two, when the reference group is the past month timeframe, the b = 
1.38, SE = 1.86, t(22.09) = 0.74, p = .466. The right now difference score did not 
significantly predict sore throat composite scores at interview two, when the 
reference group is the past week timeframe, the b = 2.15, SE = 1.86, t(22.09) = 
1.15, p = .262.  There was no difference in the relationship between the right now 
difference score and the outcome based on the timeframes; the relationship 
between past week did not differ from past six months (b = -2.07, SE = 1.63, t(26) 
= -1.27,  p = .22) and the relationship between past month did not differ from past 
six months (b = -2.83, SE = 1.63, t(26) = -1.74, p = .09).  The within variance of 
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the distribution residuals was 14.50 and the between variance of distribution 
residuals was 23.52. The ICC score was calculated as .58, suggesting that 58 
percent of the variance in predicting sore throat scores at interview two was 
explained by the  nesting of individual factors and the right now difference score. 
Concentration 
  The right now difference score significantly predicted concentration 
composite scores at interview two, when the reference group was the six month 
timeframe, b = 2.11, SE = 0.93, t(56.40) = 2.27, p = .03. The right now difference 
score only marginally predicted concentration composite scores at time two, when 
the reference group was the past month, b = 1.68, SE = 0.93, t(56.40) = 1.80, p = 
.078. The right now difference score did not significantly predict concentration 
scores at time two, when the reference group was the past month timeframe, b = 
1.35, SE = 0.93, t(56.40) = 1.45, p =.153. There was no difference in the 
relationship between the concentration difference score and the outcome scores 
based on the timeframes;  past week did not differ from past six months (b = 1.68, 
SE = 0.59, t(86) = -0.746,  p = .46) and past month does not differ from past six 
months, b = 1.35, SE = 0.59, t(86) = -1.30, p = .196. The within variance of the 
distribution residuals was 7.49 and the between variance of distribution residuals 
was 30.40. The ICC score was calculated as .80, suggesting that 80 percent of the 
variance in predicting sore throat scores at interview two is explained by the 
nesting of individual factors and the right now difference score. 
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 For research question Ia, it was asked, what is the optimal recall timeframe 
in terms of test-retest reliability, for ME/CFS symptoms that are perceived as 
variable/unstable over time? Research question Ib was supplementary to Ia and 
reads, what is the optimal recall timeframe in terms of test-retest reliability, for 
ME/CFS symptoms that are perceived as stable over time?  
A multilevel model was used in the analysis of research question Ia and Ib. 
In the model presented below, the outcome variable represents the symptom 
composite scores reported at interview two. For ease of description, level 2 of the 
model tested (1) the extent that symptom composite scores at interview one 
predicted composite scores at interview two, and (2) how timeframe moderated 
the way symptom composites at interview one predicted scores at interview two. 
Level 1 of the model tested the main effect of timeframe. Analyses for research 
question Ia and Ib were both conducted using the formula listed below selecting 
out for variable and stable symptoms. Grand mean centering was conducted for 
the Level 2 variables, so as to ease interpretation. 
 
 Level 1: yij= b0i + b1i Past Week Vs Six Months ij + b2i Past Month Vs  
        Six Months ij + rij 
Level 2: b0i= γ00 +  γ01  Symptom Score at Interview One i+ ri 
        b1i= γ10 + γ11 Symptom Score at Interview One i 
    b2i= γ20 + γ21 Symptom Score at Interview One i 
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Variable Sore Throats 
  When sore throats were rated as variable, sore throat composite scores at 
interview one significantly predicted sore throat composite scores at interview 
two, for the six month reference, b =  0.80, SE = 0.17, t(62.39) = 4.81, p < .001. 
The relationship between interview one and interview two is significantly stronger 
for the six month timeframe compared to the past week (b = 0.20, SE = 0.28,  
t(65.03) =  -2.1, p = .04) and the past month (b = -0.04, SE = -0.84, t(60.62) = -
2.28, p=.026). The slope coefficient for the six month reference was closest to 1.0 
at .80, suggesting that six months is the optimal timeframe for variable sore 
throats. The within variance of the distribution residuals was 3.83 and the between 
variance of distribution residuals was 21.26. The ICC score was calculated as .85, 
suggesting that 85 percent of the variance in predicting variable sore throat scores 
at interview two is explained by the nesting of both individual factors and the sore 
throat scores at interview one. 
Stable Sore Throats 
Sore throat scores at interview one did not significantly predict sore throat 
scores at interview two, when the reference was the past six months, b = 0.18, SE 
= 0.76,  t(16.67) = 0.23,   p = .819,  the past month, b = 1.84, SE = 1.34, t(15.13) 
= 1.38, p = .188, or the past week, b = -0.97, SE = 0.85, t(16.25) = -1.15, p = .268.  
There is no difference in the relationship between the sore throat scores at 
interview one and interview two based on the timeframes; the relationship 
between past six months does not differ from the past month (b = 1.84, SE = 1.63, 
t(16.73) = 1.02, p = .322) or from the past week (b = -0.97, SE = 1.29, t(17.85) = -
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0.90, p = .380). The slope coefficient for the six month reference was closest to 
1.0 at 0.18, suggesting that six months is the optimal timeframe for variable sore 
throats. Although six months was determined as optimal, all three timeframes 
produced slope coefficients with poor predictive validity relative to the other 
symptoms, suggesting that  within the study population, there is poor reliability in 
reporting sore throats that are experienced as stable. The within variance of the 
distribution residuals was 19.76 and the between variance of distribution residuals 
was 17.01. The ICC score was calculated as .46, suggesting that 46 percent of the 
variance in predicting stable sore throat scores at interview two is explained by 
the nesting of individual factors and sore throat scores at interview one. 
Variable Lymph Node Pain. 
 When lymph node pain was rated as variable over time, lymph node 
scores at interview one significantly predicted lymph node scores at interview two 
for the six month reference,  b = 0.77, SE = 0.28, t(47.43) = 2.71, p = .009. 
Interview one did not significantly predict lymph node scores at interview two for 
the past month reference, b = 0.07, SE = 0.33, t(46.08) = 0.22, p = .824, or the 
past week interval, b = 0.03, SE = 0.29,  t(47.25) = 0.12, p = .91. There is no 
difference in the relationship between the lymph node scores at interview one and 
interview two based on the timeframes; the relationship between past six months 
does not differ from the past month (b = 0.07, SE = 0.47, t(47.90) = -1.48, p = 
.145) or from the past week (b = 0.03, SE = 0.45, t(49.67) = -1.619, p = .112). The 
six month slope coefficient was closest to 1.0 at .77, suggesting that six months is 
the optimal timeframe for lymph node pain experienced as variable. The within 
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variance of the distribution residuals was 3.44 and the between variance of 
distribution residuals was 11.52. The ICC score was calculated as .77, suggesting 
that 77 percent of the variance in predicting variable sore lymph node scores at 
interview two is explained by the nesting of individual factors and sore throat 
scores at interview one. 
Stable Lymph Node Pain 
  When lymph node pain was rated as stable over time, lymph node scores 
at interview one significantly predicted lymph node scores at interview two, for 
the six month reference, b = 1.30, SE = 0.49, t(28.53) = 2.63,  p = .014.  Lymph 
node scores at interview one did not significantly predict scores at interview two 
for the past month, b = 0.30, SE = 0.86, t(26.62) = 0.35, p = .731, or the past 
week, b = 0.12, SE = 0.60,  t(29.83) = 1.29, p = .847. There is no difference in the 
relationship between the lymph node scores at interview one and interview two 
based on the timeframes; the relationship between past six months does not differ 
from the past month (b = 0.30, SE = 1.12, t(28.70) = -0.89, p  = .380) or from the 
past week, b = 0.12,  SE = 0.92,  t(29.83) = -1.29,  p = .207. The six month slope 
coefficient was closest to 1.0 at 1.30, suggesting that six months is the optimal 
timeframe for lymph node pain experienced as stable. The within variance of the 
distribution residuals was 7.86 and the between variance of distribution residuals 
was 31.44. The ICC score was calculated as .80, suggesting that 80 percent of the 
variance in predicting stable lymph node scores at interview two is explained the 
nesting of individual factors and stable lymph node scores at interview one. 
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Variable Post-Exertional Malaise 
 When PEM was rated as variable, PEM scores at interview one did not 
significantly predict PEM scores at interview two, for the past six month 
reference, b = 0.31, SE = 0.45, t(6.93) = 0.68, p = .518,  the past month, b = 0.44, 
SE = 0.63, t(6.35) = 0.71,  p = .505, or the past week, b = -0.29,  SE = 0.47,  
t(6.84) = -.62, p = .557. There was no difference in the relationship between PEM 
scores at interview one and at interview two based on the timeframes; the 
relationship between six months did not differ from past month (b = 0.44,  SE =  
0.82,  t(6.94) = 0.16, p = .875) or from the past week (b = -0.29, SE = 0.73, t(7.72) 
= -0.82 p = .438).  The slope coefficient for the past month reference is closest to 
1.0 at .44, suggesting that the past month timeframe is optimal for PEM that is 
experienced as variable.  All three timeframes produced slope coefficients with 
poor predictive validity relative to the other variable symptoms, suggesting that  
within this study population, there is poor reliability in reporting PEM that is 
experienced as variable. The within variance of the distribution residuals was 7.23 
and the between variance of distribution residuals was 9.66. The ICC score was 
calculated as .57, suggesting that 57 percent of the variance in predicting variable 
PEM scores at interview two is explained by the nesting of individual factors and 
variable PEM scores at interview one. 
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Stable Post-Exertional Malaise 
When PEM scores were rated as stable over time,  PEM scores at 
interview one significantly predicted PEM scores at interview two for the six 
month reference, b = 0.79, SE = 0.19, t(106.85) = 4.09, p < .001 and at the past 
week reference, b = 0.44, SE = 0.21, t(104.93) = 2.13, p = .04. There was no 
difference in the relationship between PEM scores at interview one and at 
interview two based on the timeframes; the relationship between six months does 
not differ from past month, b = 0.30, SE= 0.33, t(109.37) = -1.5, p = .142, or from 
the past week, b = 0.44, SE = 0.32, t(112.91) = -1.09, p = .275. The slope 
coefficient for the six month reference is closest to 1.0 at .79, suggesting that the 
six month timeframe is optimal for reporting PEM experienced as stable. The 
within variance of the distribution residuals was 7.01 and the between variance of 
distribution residuals was 14.82. The ICC score was calculated as .68, suggesting 
that 68 percent of the variance in predicting stable PEM scores at interview two is 
explained the nesting of individual factors and stable PEM scores at interview 
one. 
Variable Muscle Pain 
When muscle pain was rated as variable over time, muscle pain scores at 
interview one significantly predicted muscle pain scores at interview two for the 
six month reference, b = 0.56,  SE = 0.25,  t(40.21) = 2.25, p = .03. Interview one 
did not significantly predict muscle pain scores at interview two for the past 
month reference, b = -0.22, SE = 0.36, t(38.12) = -0.60, p = .553, or the past week 
b = -0.23, SE = 0.24, t(40.54) = -0.98, p = .335. The relationship between 
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interview one and interview two for the six month timeframe is marginally 
stronger compared to the past week, b = -0.23, SE = 0.40, t(42.70) = -1.99, p = 
.054, and the past month b = -0.22, SE = .45, t(38.79) = -1.73, p = .09. The slope 
coefficient at the past six month interval is closest to 1.0 at .56, suggesting that the 
past six month timeframe is optimal for reporting muscle pain experienced as 
variable. The within variance of the distribution residuals was 3.28 and the 
between variance of distribution residuals was 12.65. The ICC score was 
calculated as .79, suggesting that 79 percent of the variance in predicting variable 
muscle pain scores at interview two is explained the nesting of individual factors 
and variable muscle pain scores at interview one. 
Stable Muscle Pain 
  When muscle pain scores were rated as stable over time, muscle pain 
scores at interview one marginally predicted scores at interview two for the six 
month reference, b = 0.82, SE = 0.44, t(72.40) = 1.86, p = .067. Interview one 
scores did not predict interview two scores for the past month, b = 0.75, SE = 
0.55, t(69.15) = 1.35, p = .182, or the past week, b = -0.23, SE = 0.24, t(40.54) = -
.98, p = .335.  The relationship between interview one and interview two was 
significantly stronger at the six month reference compared to the past week (b = -
0.56, SE = 0.66, t(79.89) = -2.08, p = .041). The relationship between interview 
one and interview two for the past six months was no different than the past 
month (b = 0.75, SE = 0.72, t(69.93) = -1.02, p = .919). The slope coefficient at 
the six month interval is closest to 1.0 at .82, suggesting that the past six month 
timeframe is optimal for reporting muscle pain experienced as stable. The within 
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variance of the distribution residuals was 13.75 and the between variance of 
distribution residuals was 16.70. The ICC score was calculated as .55, suggesting 
that 55 percent of the variance in predicting stable muscle pain scores at interview 
two is explained by the nesting of individual factors and stable muscle pain scores 
at interview one. 
Variable Joint Pain 
  When joint pain was rated as variable, scores at interview one marginally 
predicted scores at interview two, for the past week reference, b = 0.58, SE = 
0.29, t(47.81) = 2.00, p = .051. Interview one does not significantly predict joint 
pain scores at interview two, for the past month, b = 0.15, SE = 0.33, t(47.35) = 
0.45, p = .655, or the past six months, b = 0.22, SE = 0.21, t(49.54) = 1.04, p = 
.304. There is no difference in the relationship between joint pain scores at 
interview one and at interview two based on the timeframes; the relationship 
between past week does not differ from past month (b = 0.15, SE = 0.38, t(42.77) 
= 1.14, p = .260) or from the past six months, (b = 0.22, SE = 0.43, t(51.05) = 
0.85, p=.399). The slope coefficient for the past week is closest to 1.0 at .58, 
suggesting that the past week timeframe is optimal for reporting joint pain 
experienced as variable. The within variance of the distribution residuals was 3.29 
and the between variance of distribution residuals was 19.35. The ICC score was 
calculated as .85, suggesting that 85 percent of the variance in predicting variable 
joint pain scores at interview two is explained by variable joint pain scores at 
interview one. 
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Stable Joint Pain 
 When joint pain was rated as stable over time, joint pain scores at 
interview one significantly predicted joint pain scores at interview two for the six 
month reference, b = 0.95, SE = 0.35, t(46.75) = 2.72, p = .009, and the past 
month reference, b = 1.82, SE = .53, t(43.62) = 3.43, p=.001. Interview one scores 
did not significantly predict interview two scores for the past week, b = -0.64, SE 
= 0.37, t(46.25) = -1.74, p = .089.  The relationship between joint pain scores at 
interview one and interview two was significantly different by timeframe; the 
relationship at the past six months was significantly stronger compared to the past 
week (b = -0.64, SE = 0.58, t(49.57) = -2.72, p = .009) but not significantly 
stronger than the past month (b = 1.82, SE = 0.68,  t(45.98) = 1.28, p = .206). The 
slope coefficient for the past six month interval is closest to 1.0 at .95, suggesting 
that the past six month timeframe is optimal for reporting joint pain experienced 
as stable. The within variance of the distribution residuals was 8.48 and the 
between variance of distribution residuals was 25.99. The ICC score was 
calculated as .75, suggesting that 75 percent of the variance in predicting stable 
joint pain scores at interview two is explained by the nesting of individual factors 
and stable joint pain scores at interview one. 
Variable Unrefreshing Sleep 
When unrefreshing sleep was rated as variable, unrefreshing sleep scores 
at interview one did not significantly predict scores at interview two for the past 
six month timeframe, b = 0.30, SE = 0.56, t(17.71) = 0.54, p = .598,  the past 
month,   b = 0.82, SE = 0.67, t(17.22) = 1.22, p = .238, or the past week 
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timeframe, b = 0.64, SE = 0.48, t(18.35) = 1.33, p = .199. There was no difference 
in the relationship between unrefreshing sleep scores at interview one and at 
interview two based on the timeframes; the relationship between interview one 
and two at the past month timeframe does not differ from past six months (b = 
0.30, SE = 0.86, t(16.82) = 0.60, p = .557) or from the past week (b = 0.64, SE = 
0.91, t(18.64) = -.20 p = .844). The slope coefficient at the past month reference is 
closest to 1.0 at .82, suggesting that the past month timeframe is optimal for 
reporting unrefreshing sleep experienced as variable. The within variance of the 
distribution residuals was 6.90 and the between variance of distribution residuals 
was 20.81. The ICC score was calculated as .75, suggesting that 75 percent of the 
variance in predicting variable unrefreshing sleep scores at interview two is 
explained by the nesting of individual factors and unrefreshing sleep scores at 
interview one. 
Stable Unrefreshing Sleep 
 When unrefreshing sleep was rated as stable, unrefreshing sleep scores at 
interview one significantly predicted unrefreshing sleep scores at interview two 
when the interval was six months, b = 0.41, SE = 0.17, t(95.17) = 2.34, p = .021. 
Unrefreshing sleep at interview one did not significantly predict unrefreshing 
sleep at interview two, for the past month reference, b = 0.29, SE = 0.23, t(91.14) 
= 1.24, p = .218 or the past week, b = 0.18, SE = 0.26, t(89.80) = 0.67, p = .504. 
There was no difference in the relationship between unrefreshing sleep scores at 
interview one and at interview two based on the timeframes; the relationship 
between interview one and two at the six month timeframe does not differ from 
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past month (b = 0.29, SE = 0.34, t(98.72) = -0.37,  p = .713) or from the past week 
(b = 0.18, SE = 0.36,  t(97.29) = -0.64,  p = .525). The slope coefficient at the six 
month reference was closest to 1.0 at .41, suggesting that the six month timeframe 
is optimal for reporting unrefreshing sleep experienced as stable. The within 
variance of the distribution residuals was 5.90 and the between variance of 
distribution residuals was 22.79. The ICC score was calculated as .79, suggesting 
that 79 percent of the variance in predicting stable unrefreshing sleep scores at 
interview two is explained by the nesting of individual factors and stable 
unrefreshing sleep scores at interview one. 
Variable Headaches 
Headache scores at interview one did not significantly predict headache 
scores at interview two, for the six month reference, b = 0.32, SE = 0.24, t(74.54) 
= 1.30, p = .197,  the past month, b = -0.51, SE = 0.36,  t(69,80) = -1.42,  p = .159, 
or the past week reference, b = -0.08, SE = 0.22, t(76.77) = -.37, p = .711. The 
relationship between headaches at interview one and two at the past six months 
was marginally different from the past month (b = -0.51, SE = 0.43, t(68.40) = -
1.93, p = .058) but was not significantly different from the past week (b = -0.08,  
SE =  0.37, t(82.31) = -1.07, p = .289). The slope coefficient at the past six month 
reference is closest to 1.0 at .32, suggesting that the six month timeframe is 
optimal for reporting headaches experienced as variable. The within variance of 
the distribution residuals was 8.21 and the between variance of distribution 
residuals was 12.50. The ICC score was calculated as .60, suggesting that 60 
percent of the variance in predicting variable headache scores at interview two is 
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explained by the nesting of individual factors with variable headache scores at 
interview one. 
Stable Headaches 
  When headaches were rated as stable over time, headache scores at 
interview one significantly predicted headache scores at interview two, when the 
reference was six months, b = 1.40, SE = 0.23, t(30.36) = 6.04, p < .001. 
Headache scores at interview one did not significantly predict headache scores at 
interview two at the past month, b = 0.30, SE = 0.48, t(27.75) = 0.62, p = .543, or 
the past week, b = 0.00, SE = 0.24,  t(30.17) = 0.01, p = .991. The relationship 
between Headache scores at interview one and headache scores at interview two 
was significantly stronger at the past six month reference compared to the past 
week    (b = 0.00, SE = 0.39, t(32.27) = -3.55,  p = .001) and marginally stronger 
than the past month (b = 0.30, SE = 0.56, t(28.85)= -1.98, p = 0.058). The slope 
coefficient at the past six month reference is closest to 1.0 at 1.40, suggesting that 
the six month timeframe is optimal for reporting headaches that are stable. The 
within variance of the distribution residuals was 8.63 and the between variance of 
distribution residuals was 36.75. The ICC score was calculated as .81, suggesting 
that 81 percent of the variance in predicting variable headache scores at interview 
two is explained by the nesting of individual factors and headache scores at 
interview one. 
Variable Memory Problems 
  Memory scores at interview one did not significantly predict Memory 
scores at interview two for the six month reference, b = -0.14, SE = 0.29, t(39.71) 
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=  -0.50,  p = .618,  the past month, b = -0.07,  SE = 0.45,  t(37.23) = -0.15,  p = 
.881, or the past week interval, b = -0.14,  SE = 0.34, t(38.47) = -.41, p = .688. 
There was no difference in the relationship between memory scores at interview 
one and at interview two based on the timeframes;  the past six months was not 
significantly different from the past month, b = -0.07, SE = 0.59,  t(40.01) = 0.13, 
p = .898 or from the past week, b = -0.14,  SE = 0.52,  t(41.43) =  0.01,  p = .991. 
The slope coefficient for the past month reference is closest to 1.0 at -.07, 
suggesting that the six month timeframe is optimal for reporting variable memory 
problems.  Although the past month reference was determined as optimal, all 
three timeframes produced slope coefficients with poor predictive validity, 
suggesting that  within this study population, there is poor reliability in reporting 
memory problems that are experienced as variable. The within variance of the 
distribution residuals was 7.22 and the between variance of distribution residuals 
was 28.07. The ICC score was calculated as .80, suggesting that 80 percent of the 
variance in predicting variable memory scores at interview two is explained by 
the nesting of individual factors and memory scores at interview one. 
Stable Memory Problems 
  When memory problems were rated as stable over time, memory scores at 
interview one significantly predicted memory scores at interview two, when the 
reference was six months, b = 1.03, SE = 0.19, t(60.72) = 5.32, p < .001. Memory 
scores at interview one did not significantly predict memory scores at interview 
two at the past month, b = 0.04, SE = 0.29, t(59.13) = .14, p = .893, or the past 
week, b = -0.17, SE = 0.21, t(60.32) = -8.26,  p = .412. The relationship between 
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memory scores at interview one and memory scores at interview two was 
significantly stronger at the past six months compared to the past week (b = -0.17, 
SE = 0.33, t(61.88) = -3.61,  p = 0.001) and the past month (b = 0.04, SE = 0.38, 
t(60.42) = -2.63, p = .011). The slope coefficient at the past six month interval is 
closest to 1.0 at 1.03, suggesting that the six month timeframe is optimal for 
reporting memory problems experienced as stable. The within variance of the 
distribution residuals was 3.62 and the between variance of distribution residuals 
was 41.44. The ICC score was calculated as .92, suggesting that 92 percent of the 
variance in predicting stable memory scores at interview two is explained by 
stable memory scores at interview one. 
Variable Concentration Problems 
  When concentration scores were experienced as variable, concentration 
scores at interview one did not significantly predict concentration scores at 
interview two for the six month reference, b = 0.20,  SE = 0.43,  t(35.81) = 0.46, p 
= .647,  the past month, b = -0.17, SE = 0.37, t(36.39) = -0.45,  p = .654, or the 
past week reference, b = 0.04, SE = 0.27, t(39.80) = 0.27, p = .786. There was no 
difference in the relationship between concentration scores at interview one and at 
interview two based on the timeframes;  the past six months was not significantly 
different from the past month (b = -0.17, SE = 0.51,  t(29.98) = -0.73,  p = .473) or 
the past week (b = 0.04, SE = 0.58, t(39.80) = -0.27,  p = .786). The slope 
coefficient at the six month reference is closest to 1.0 at .20, suggesting that the 
six month timeframe is optimal for reporting variable concentration problems. 
Although the six month interval was determined as optimal, all three timeframes 
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produced slope coefficients with poor predictive validity, suggesting that  within 
the current population, there is poor reliability in reporting concentration 
problems that are experienced as variable. The within variance of the distribution 
residuals was 8.00 and the between variance of distribution residuals was 15.87. 
The ICC score was calculated as .66, suggesting that 66 percent of the variance in 
predicting variable concentration scores at interview two is explained by the 
nesting of individual factors and concentration scores at interview one. 
Stable Concentration Problems 
When concentration problems were rated as stable over time, 
concentration scores at interview one significantly predicted concentration scores 
at interview two, when the reference was six months, b = 0.47, SE = 0.23, t(74.15) 
= 2.07, p = .042. Concentration scores at interview one did not significantly 
predict concentration scores at interview two for the past month reference, b = 
0.14, SE = 0.30, t(71.73) = 0.48, p = .634, or the past week, b = -0.43,  SE = 0.31,  
t(71.52) = -1.41,  p = .164. The relationship between concentration scores at 
interview one and concentration scores at interview two was significantly stronger 
at the past six month interval compared to the past week (b = -0.43,  SE = 0.44, 
t(75.46) = -2.05,  p = .044) and the past month (b = 0.14, SE = 0.43, t(75.68) = -
0.76, p = .451). The slope coefficient for the six month reference is closest to 1.0 
at .47, suggesting that the six month timeframe is optimal for reporting stable 
concentration problems. The within variance of the distribution residuals was 
19.76 and the between variance of distribution residuals was 17.00. The ICC 
score was calculated as .46, suggesting that 46 percent of the variance in 
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predicting stable concentration scores at interview two is explained by the nesting 
of individual factors and stable concentration scores at interview one (see Table 4 
for slope coefficients of variable ME/CFS symptoms at all three timeframes; see 
Table 5 for slope coefficients of stable ME/CFS symptoms at all three 
timeframes). 
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Table 4 
Slope Coefficients of Variable ME/CFS symptoms at Three Timeframes 
  
Note.  The symbol * refers to the optimal timeframe (coefficients closest to 1.0) 
 
Variable Symptoms Timeframe b SE df t p 
Sore Throat Week 0.20 0.17 61.99 1.19 .239 
 Month -0.04 0.31 58.68 -.14 .888 
 Six Months* 0.80 0.17 62.39 4.81 <.001 
Lymph Node Pain Week 0.03 0.29 47.25 0.12 .91 
 Month 0.07 0.33 46.08 0.22 .824 
 Six Months* 0.77 0.28 47.43 2.71 .009 
PEM Week -0.29 0.47 6.84 -0.62 .557 
 Month* 0.44 0.63 6.35 0.706 .505 
 Six Months 0.31 0.45 6.93 0.68 .518 
Muscle Pain Week -0.23 0.24 40.54 -0.98 .335 
 Month -0.22 0.36 38.12 -0.60 .553 
 Six Months* 0.56 0.25 40.21 2.25 .03 
Joint Pain Week* 0.58 0.29 47.81 2.00 .051 
 Month 0.15 0.33 47.35 0.45 .655 
 Six Months 0.22 0.21 49.54 1.04 .304 
Unrefreshing Sleep Week 0.64 0.48 18.35 1.33 .199 
 Month* 0.82 0.67 17.22 1.22 .238 
 Six Months 0.30 0.56 17.71 0.54 .598 
Headaches Week -0.08 0.22 76.77 -0.37 .711 
 Month -0.51 0.36 69.80 -1.42 .159 
 Six Months* 0.32 0.24 74.54 1.30 .197 
Memory Week -0.14 0.34 38.47 -0.41 .688 
 Month* -0.07 0.45 37.23 -0.15 .881 
 Six Months -0.14 0.29 39.71 -0.50 .62 
Concentration Week 0.04 0.27 39.80 0.27 .786 
 Month -0.17 0.37 36.39 -0.45 .654 
 Six Months* 0.20 0.43 35.81 0.46 .647 
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Table 5 
Slope Coefficients of Stable ME/CFS symptoms at Three Timeframes 
 
  
Note.  The symbol * refers to the optimal timeframe (coefficients closest to 1.0) 
Stable Symptoms Timeframe b SE df t p 
Sore Throat Week -0.97 0.85 16.25 -1.15 .268 
 Month 1.84 1.34 15.13 1.38 .188 
 Six Months* 0.18 0.76 16.67 0.23 .819 
Lymph Node Pain Week 0.12 0.60 29.83 1.29 .847 
 Month 0.30 0.86 26.62 .347 .731 
 Six Months* 1.30 0.49 28.53 2.63 .014 
PEM Week 0.44 0.21 104.93 2.13 .04 
 Month 0.30 0.23 102.45 1.31 .195 
 Six Months* 0.79 0.19 106.85 4.09 <.001 
Muscle Pain Week -0.56 0.40 74.44 -1.41 .164 
 Month 0.75 0.55 69.15 1.35 .182 
 Six Months* 0.82 0.44 72.40 1.86 .067 
Joint Pain Week -0.64 0.37 46.25 -1.74 .089 
 Month 1.82 0.53 43.62 3.43 .001 
 Six Months* 0.95 0.35 46.75 2.72 .009 
Unrefreshing Sleep Week 0.18 0.26 89.80 0.67 .504 
 Month 0.29 0.23 91.14 1.24 .218 
 Six Months* 0.41 0.17 95.17 2.34 .021 
Headaches Week 0.00 0.24 30.17 0.012 .991 
 Month 0.30 0.48 27.75 0.62 .543 
 Six Months* 1.40 0.23 30.36 6.04 <.001 
Memory Week -0.17 0.21 60.32 -8.26 .412 
 Month 0.04 0.29 59.13 0.14 .893 
 Six Months* 1.03 0.19 60.72 5.32 <.001 
Concentration Week -0.43 0.31 71.52 -1.41 .164 
 Month 0.14 0.30 71.73 .48 .634 
 Six Months* 0.47 0.23 74.15 2.07 .042 
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 For research question II it was asked, does the optimal recall timeframe in 
terms of test-retest reliability, differ significantly by the ME/CFS symptom 
measured? A multilevel statistical model was used to test Research question II. 
Level 1 of the model tested (1) the main effect of timeframe, (2) the extent that 
symptom composite scores at interview one predicted composite scores at 
interview two, (3) the interaction of timeframe and symptom composite scores at 
interview one in predicting scores at interview two, and (4) how symptom type 
moderated the way symptom composite scores at interview one predicted 
composite scores at interview two.  Level 2 of the model tested the main effect of 
symptom type. The variable Symptom Type included in the model below, 
represents all nine ME/CFS symptoms, each with a designated code (e.g. Sore 
throat = 1, Lymph Node = 2…etc). Group mean centering was conducted for the 
Level 1 continuous variables, so as to control for the influence of between-person 
variance on the slope coefficients. 
Level 1: yij= b0i + b1 Timeframe + b2 Symptom Composite Score at Interview One 
+ b3 Timeframe (Symptom Composite Score at Interview One) +  rij 
     y= Symptom Score at Interview Two 
Level 2: b0i = γ00 +  γ01 Symptom Type + υij 
     b1i= γ10 + γ11 Symptom Type  
   b2i= γ20 + γ21 Symptom Type  
   b3i= γ30 + γ31 Symptom Type  
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 The omnibus F test revealed that symptom scores at interview one 
significantly predicted symptom scores at interview two, F(1, 1273.30) = 
1435.34, p < .001. There was a significant main effect of symptom type (F(8, 
1275.66) = 11.17, p < .001) but not a significant main effect of timeframe, (F(2, 
1273.88) = 1.97, p = .139). There were no significant two-way interactions, such 
that timeframe by interview one scores (F(2, 1275.92) = 1.79, p =.168), symptom 
type by interview one scores (F(8, 1282.22) = 1.71, p =.091), and timeframe by 
symptom type, (F(16, 1273.32) = 0.36, p = .990) were all insignificant.  
Additionally, There was not a significant three way interaction between 
timeframe, symptom type, and interview one symptom scores, F(16, 1273.67) = 
0.343, p = .993; hence, the optimal recall timeframe does not differ by the 
ME/CFS symptom being measured.  
Research question III is supplemental, and speculates, what the optimal 
recall timeframe is in terms of test-retest reliability, in the absence of contextual 
factors (e.g. stability and momentary symptom severity scores)? For ease of 
description, level 2 of the model tested (1) the extent that symptom composite 
scores at interview one predicted composite scores at interview two, and (2) how 
timeframe moderated the way symptom composite scores at interview one 
predicted scores at interview two. Level 1 of the model tested the main effect of 
timeframe. Analyses for research question III were conducted using all ME/CFS 
symptom scores regardless of stability ratings. Grand mean centering was 
conducted for the Level 2 variables, so as to ease interpretation. 
 
54 
 
 
Level 1: yij= b0 + b1Past Week Vs Six Months ij + b2 Past Month Vs  
Six  Months ij + rij 
                      y= Symptom Score at Interview Two 
Level 2: b0i= γ00 +  γ01  Symptom Score at Interview One i + υij 
      b1i= γ10+ γ11 Symptom Score at Interview One i 
   b2i= γ20 + γ21 Symptom Score at Interview One i 
 
Results of the above analyses revealed that the slope coefficients for all 
but one symptom (e.g. all except joint pain) were optimal at the six month 
timeframe in reliably reporting ME/CFS symptoms, in the absence of contextual 
level two factors (stability and momentary severity).  The slope coefficient for 
joint pain scores reveal that the past month is optimal for reliably reporting joint 
pain (Please see Table 6 for slope coefficients of ME/CFS symptoms rated at all 
three timeframes without contextual factors).  
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Table 6 
Slope Coefficients of ME/CFS symptoms across timeframe Sans Stability 
 
Note.  The symbol * refers to the optimal timeframe (coefficients closest to 1.0) 
All Symptoms Timeframe b SE df t p 
Sore Throat Week -0.06 0.19 11.40 -0.30 .763 
 Month 0.33 0.33 105.04 1.01 .316 
 Six Month* 0.75 0.18 112.63 4.25 <.001 
Lymph Node Pain Week -.10 0.24 105.42 -0.42 .678 
 Month .12 0.30 103.33 0.39 .698 
 Six Month* 1.15 0.22 106.95 5.28 <.001 
PEM Week 0.30 0.19 116.47 1.57 1.20 
 Month 0.28 0.22 112.99 1.29 .201 
 Six Month* 0.72 0.18 118.12 3.98 <.001 
Muscle Pain Week -0.48 0.25 117.12 -1.87 .064 
 Month 0.43 0.36 109.84 1.19 .236 
 Six Month* 0.74 0.28 114.81 2.68 .009 
Joint Pain Week -0.09 0.25 108.39 -.358 .721 
 Month* 0.81 0.32 105.77 2.53 .013 
 Six Month 0.54 0.21 111.03 2.60 .010 
Unrefreshing Sleep Week 0.29 0.23 107.74 1.27 .207 
 Month 0.35 0.21 108.34 1.63 1.63 
 Six Month* 0.47 0.16 112.28 2.84 .005 
Headaches Week -0.01 0.16 118.48 -0.09 .932 
 Month -0.33 0.28 108.24 -1.18 .240 
 Six Month* 0.92 0.17 117.52 5.43 <.001 
Memory Week -0.09 0.20 105.52 -0.45 .656 
 Month 0.02 0.26 103.15 0.09 .933 
 Six Month* 0.38 0.17 107.16 2.20 .03 
Concentration Week -0.18 0.19 107.62 -0.96 .338 
 Month 0.06 0.22 105.14 0.29 .770 
 Six Month* 0.42 0.19 107.33 2.24 .027 
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CHAPTER IV 
DISCUSSION 
 The following chapter provides a review of the major findings from this 
study as well as implications for future work and research in the ME/CFS field. 
Limitations of the study are also identified and recommendations for future 
research in this area are presented.  
Major Findings and Implications 
 The present study served as an investigation of the impact of contextual 
factors (e.g. timeframe, symptom stability, and momentary symptom severity) on 
the test-retest reliability of ME/CFS symptom composite scores (frequency 
multiplied by severity) across two assessment points. Results of hypothesis I, 
which tested the impact of symptom stability on reliability, revealed that symptom 
stability significantly and positively impacted test-retest reliability for post-
exertional malaise (PEM), headaches, and memory problems, such that the more 
stable the symptom was perceived to be over time, the better participants‟ 
symptoms scores at interview one were in predicting scores at interview two. 
 Prior research supports the finding that greater stability can improve recall 
(Stone & Shiffman, 2002; Stull et al., 2009); however, it is unclear why this 
impact of stability was found for some and not all ME/CFS symptoms.  These 
differential findings suggest that symptom stability can have a significant impact 
on the reliability of symptom reporting and that the size of the impact may depend 
on symptom type. Based on these findings, it is important for researchers and 
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health care professionals to take into account the potential impact of stability on 
symptom experience. 
 Results of hypothesis II revealed that increases in the momentary severity 
scores for concentration problems and sore throats across the two interviews, 
significantly predicted increases in concentration and sore throat composite scores 
at interview two when the reference group was the six month timeframe. These 
results were not observed at the other two timeframes (e.g. past week and past 
month) or for any of the additional ME/CFS symptoms measured.  
 Prior research has shown that mood, attitude, and health status at the time 
of an assessment can impact recall (Blaney, 1986; Broderick, Eich et al., 1985; 
Schwartz, Shiffman, Hufford,  & Stone, 2003; Stull et al., 2009). Specifically,  
Eich et al. found that respondents with increased pain at the time of an assessment 
were more likely to  recall their past pain symptoms as more severe than they had 
originally reported (1985).  Based on this research, it was expected that 
momentary symptom severity would have a wider impact on the reliability of 
symptom reports assessed at the longer timeframes (past week, past month, past 
six months). Results of the present study suggest that for the majority of ME/CFS 
symptoms, the reliability of the composite scores are not largely affected by 
momentary symptom severity. Sore throats and concentration problems however, 
do appear to be impacted by a person‟s momentary status. It is unsurprising that 
an increase over the course of one week in momentary concentration severity 
could influence a persons‟ ability to reliably recall their concentration scores at 
the longer timeframes. It is possible that this impact on reliability is due to the fact 
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that people are having difficulty concentrating on what the question is asking 
them; thus having difficulty reliably recalling their concentration problems over 
the longer timeframe. Alternatively people may be using cognitive heuristics by 
adjusting their concentration problems as worse at the longer timeframes because 
it is experienced as more severe in the moment. Results showed that the shift in 
scores at the longer timeframes were in the same positive direction as the 
momentary changes in score, suggesting that the latter explanation is plausible.  
One possible explanation for why changes in momentary sore throat 
severity impact recall at the six month period, is that the majority of participants 
rated their sore throat scores as variable over the six month period (see Table 2 
and Table 3) and this instability in symptom experience may make sore throats 
more susceptible to cognitive biases. For instance, Bradburn, Rips, and Shevell 
(1987), and Bradburn (2000) assert that when respondents are asked to report on 
highly fluctuating symptoms at a longer timeframe, they are more likely to use 
cognitive heuristics for this highly complex task. Furthermore, these adjustments 
and short-cuts may be more susceptible to contextual factors such as momentary 
severity.   As the recall timeframe gets longer, the task becomes more complex for 
the respondent, and it becomes more likely that a respondent will rely on 
cognitive short-cuts to answer the question; thus providing a possible explanation 
for why changes in momentary severity only significantly impacted symptom 
reports at the six month timeframe rather than the past month or past week.  Given 
these findings, it may be important for researchers and physicians to take into 
account current health status when acquiring retrospective reports of certain  
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symptoms, especially when symptoms are highly fluctuating or reported over a 
longer timeframe. 
  Results of research question Ia revealed that the optimal timeframe for 
ME/CFS symptoms perceived as variable over time, differed across symptoms. 
The past six months was observed as the optimal timeframe for five of the nine 
symptoms measured (e.g. sore throat, lymph node, muscle pain, headaches, and 
concentration) whereas the past month was observed to be optimal for reporting  
PEM,  unrefreshing sleep, and memory problems. Lastly, the past week timeframe 
was found to be optimal for variable joint pain. While an optimal timeframe could 
be identified for each ME/CFS symptom, it is important to note that four 
symptoms (e.g. PEM, headache, memory, and concentration) had relatively weak 
slope coefficients, suggesting that when these symptoms are perceived as variable 
over time, they are not reliably recalled from one week to another. PEM and 
cognitive difficulties including memory and concentration problems are often 
cited as cardinal symptoms of the illness ME/CFS (Carruthers et al., 2003; Jason 
et al., 2010). Only five of the total 51 participants in this study reported that their 
PEM was variable over time (See Table 2) and less than half of all participants 
reported that memory and concentration was variable (19 and 16 respectively; see 
Table 2). It is possible that when key symptoms of this illness are experienced as 
variable and fluctuating, they are more difficult to recall consistently. It is also 
possible that individuals who report these symptoms as variable my represent a 
unique subset.  The majority of participants reported headaches as variable over 
time (31 out of 47; see Table 2 and Table 3); however the optimal slope 
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coefficient for this symptom was still weak at .32 suggesting that headaches have 
poor recall reliability when perceived as variable over time. These findings may 
be explained by the tendency for people to use cognitive heuristics when 
assessing variable symptoms over a longer timeframe; which in turn affects 
reliability and accuracy of reporting (Bradburn, Rips, & Shevell, 1987; Bradburn, 
2000). Due to the fact that the majority of the study population reported their 
headaches as variable, it is recommended that researchers and physicians be 
knowledgeable of the fluctuating nature of this symptom as well as the weak 
reliability in reporting the frequency and severity of this symptom over long time 
periods.  
 Results of research question Ib (supplementary) revealed that the optimal 
timeframe in terms of test-retest reliability for ME/CFS symptoms perceived as 
stable over time was highly uniform, such that all nine ME/CFS symptoms were 
more reliably recalled at the six month timeframe compared to the past week and 
past month timeframes. Stable sore throats had the weakest slope coefficients at 
all three timeframes compared to the other eight symptoms, suggesting that sore 
throats are not as reliably recalled when perceived as stable over time. 
Interestingly, the optimal slope coefficient for variable sore throats was higher 
than the optimal slope coefficient for stable sore throats. It is unclear why sore 
throats are recalled more consistently when variable and at the past six month 
timeframe. Sore throats are not widely considered a cardinal symptom of 
ME/CFS, which is supported by this study data, showing that only 38 of the total 
51 participants reported experiencing sore throats over the course of their illness 
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and 58.8 percent of these respondents reported their sore throats as variable rather 
than stable over time. Stone and colleagues (2002) assert that when a respondent 
reports about a highly variable symptom, they are making an overall assessment 
of their experience, and cannot indicate the variable nature of the symptom in a 
short time period. However, when highly variable symptoms are reported over 
longer timeframes, an individual will attempt to summarize their experience. 
Summarizing variable events over a long timeframe has been found to reduce 
reporting accuracy (Stone, Schwartz, Broderick, & Shiffman, 2005); however, in 
the case of this study, when reporting on particular symptoms, such as sore throats 
over longer timeframes, variability may actually improve recall reliability.  
 Results of research question II revealed that in the absence of contextual 
factors (e.g. stability, momentary severity), recall reliability across timeframe 
does not differ by symptom type. This is supported by the results of the 
supplementary research question III, which showed that in the absence of 
contextual factors (symptom stability and momentary severity), the optimal 
timeframe for reliably reporting ME/CFS symptoms appeared to be six months 
for all but one symptom (e.g. joint pain), which had an optimal timeframe of one 
month. While past literature shows a reduction in reporting accuracy when using 
longer recall timeframes, the results of this study show that longer timeframes 
may actually improve reliability. As mentioned previously, individuals with 
chronic illnesses may have a good grasp of their symptom pattern over time 
(Broderick et al., 2008), which may at least partially explain why individuals in 
this study were able to reliably make a global assessment of their symptoms at the 
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six month timeframe. People afflicted with a chronic illness such as ME/CFS may 
be more reliable in making a broad and global estimate of their symptoms over a 
longer timeframe because the shorter timeframe may be more susceptible to small 
changes that deviate from the normal symptom pattern.  Clarke et al. (2008) assert 
that there is a tradeoff between reporting accuracy and loss of information when 
deciding between a shorter or longer recall timeframe. Short timeframes may 
increase the accuracy of recall, but investigators risk losing valuable information 
about the true nature of the phenomena that would be better captured with a 
longer recall period. More work is needed in this area in order to determine if the 
six month timeframe is optimal in understanding the experience of ME/CFS 
symptoms.  
Limitations of Research 
 There are notable limitations of the current study. The study sample used 
was not selected through random assignment and thus participants may share 
certain characteristics that are different from the larger population of individuals 
affected by ME/CFS. For instance, a large majority of the participants were White 
women and middle aged. Based on research by Jason and colleagues (1999) we 
know that CFS occurs at higher rates in African American and Latino samples; 
therefore, the current sample may not be generalizable to the entire ME/CFS 
population.   
 Another limitation of this study was the uneven frequency of stable versus 
variable ratings for certain symptoms. These symptoms were either unevenly 
rated as stable (e.g. PEM) or variable (e.g. sore throat). Kahn (2011) asserts that 
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establishing a rule of thumb for sample size in achieving statistical power can be 
difficult because it is important to take sample size into consideration at two 
levels of data. Kahn reports that a large number of cases in each group improve 
reliability of Level 1 estimates. Monte Carlo research conducted by Maas and 
Hox (2005) reveal that samples with at least 30 Level 2 units provide sufficiently 
unbiased estimates; however, they also report that samples with only 10 Level 2 
units maybe also be sufficient.  The majority of symptom cases in this study met 
the 10 unit limit at the level 2 grouping. However, even when there are 30 units in 
the Level 2 grouping, the variance components will be biased. Therefore, Kahn 
argues that the more cases at Level 2, the better. This concern of sample size at 
Level 2 and the subsequent impact on power is most prominent for PEM and sore 
throats, which have very uneven stable versus variable ratings and also have 
groups with cases below 10.  
 Lastly, another possible limitation of this study is the potential for the 
“adjustment and anchoring” heuristic (Tversky & Kahneman, 1974) in 
influencing recall reliability across the timeframes. The adjustment and anchoring 
effect explains how people take information that they know and use that 
information as an anchor to help estimate information that they do not know. 
Steen et al. (1994) showed that individuals rating their asthma symptoms over a 
three month timeframe, first rated their asthma over the past month and used this 
rating as an anchor in order to estimate their asthma over the three month 
timeframe. It is possible that this anchoring effect was present in the current 
study; however, in an attempt to control this effect, the timeframes were spaced 
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out so that symptom ratings were not organized by symptom groupings but rather 
by timeframe groupings. For example, participants did not rate their sore throats 
at each timeframe all at once, but rather participants rated all nine symptoms at 
the first timeframe (right now) and then all nine symptoms at the second 
timeframe (past week) and so on. (see Appendix A for a visual representation of 
the questionnaire). By not positioning the different timeframes directly after the 
other for each symptom, it seems likely that the tendency for “adjustment and 
anchoring” heuristics is greatly reduced.  
Conclusion and Future Directions 
  Overall, findings from the presented study reveal that contextual factors 
do influence the reliability of reporting ME/CFS symptoms; however, not as 
dramatically as might be expected. Furthermore, the degree of impact that these 
contextual factors have on test-retest reliability may depend on the ME/CFS 
symptom being measured as well as individual characteristics of the respondent. 
Furthermore, results showed that in general, individuals with this illness are 
capable of reliably recalling the frequency and severity of their symptoms over 
longer timeframes (e.g. six months), which is contrary to what might be expected 
based on literature documenting reduced accuracy of reports using longer 
timeframes.  
 It is recommended that future research in this area explore the potential 
tradeoff between reduced reporting accuracy and gaining more information about 
a phenomenon using longer timeframes. For instance, one way of assessing the 
validity of the longer six-month timeframe is by comparing the degree of 
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convergent validity that symptom scores measured at longer timeframes have with 
other diagnostic measures. One criterion that is necessary for receiving a 
diagnosis of ME/CFS is the experience of substantial reductions in occupational, 
social, and personal activities (Fukuda, et al., 1994). Future research might assess 
the degree to which symptom ratings at each timeframe correlate with or predict 
measures of substantial reduction.  
In terms of the influence of contextual factors, it may also be conducive to 
understand additional factors that influence the reliability of symptom reporting. 
These additional factors may include recent stressful life events, social support, or 
the participants‟ stage/progression of illness. Participants of the current study 
answered questions regarding recent life events, stress, and additional health 
factors on the significant events questionnaire. Although these issues were not 
explored for the purposes of the present paper, these potentially influential factors 
will be explored in future research.  
 In sum, timeframe, symptom stability, and momentary severity do appear 
to influence the reliability in reporting ME/CFS symptoms. Furthermore, in the 
absence of stability and momentary severity, individuals were most reliable in 
reporting the majority of the nine ME/CFS symptoms over a six month 
timeframe.  It will be important for researchers who are interested in the 
assessment of ME/CFS to take these contextual factors into account, especially if 
the intended goal of the research is in standardizing and improving the methods 
used to reliably and accurately diagnose this complex illness. Accurate and 
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reliable assessment is a crucial first step in understanding and treating this 
debilitating and often misunderstood illness.   
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CHAPTER V 
SUMMARY 
Retrospective self report measures are often used in research and 
diagnostic assessment of myalgic encephalomyelitis/chronic fatigue syndrome 
(ME/CFS) (Hawk, Jason, & Torres-Harding, 2007; Jason, King, Frankenberry, & 
Jordan, 1999; King & Jason, 2005; Reeves et al., 2005). These retrospective self-
report measures are susceptible to recall bias, which has the potential to impact 
the reliability and validity of diagnostic decisions. One factor that can influence 
the magnitude of recall bias in symptom reporting, is the length of the recall 
timeframe used. Previous research has found that recall bias may increase when 
longer reporting periods are used, but very little research has been done on this 
area (Broderick et al., 2008), making it unclear what the optimal reporting period 
is for tracking health symptoms, especially for a complex chronic illness such as 
ME/CFS. 
 In order to contribute to the literature on the effects of timeframe length on 
symptom recall in individuals with ME/CFS, this study served as an investigation 
of the reliability of symptom data assessed at three recall timeframes (the past 
week, the past month, and the past six months) and at two assessment points (with 
one week in between each assessment).  Symptoms that are experienced as more 
stable in nature have been found to be recalled with greater accuracy than 
symptoms that are highly fluctuating and variable; therefore, it was predicted that 
the test-retest reliability of ME/CFS symptoms measured at the different recall 
timeframes would be strongest for those symptoms that are stable overtime. This 
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hypothesis was supported for only three of the nine ME/CFS symptoms measured 
(e.g. post-exertional malaise, headaches, and memory). 
 Another aim of the study was to investigate the influence that an 
individual‟s current symptom severity has on symptom recall at longer 
timeframes. It was predicted that an increase (worsening) in  momentary symptom 
severity ratings from baseline to assessment two, would predict an increase in the 
recall of symptom frequency and severity scores at longer timeframes. Similarly, 
it was expected that a decrease in momentary symptom severity ratings from 
week one to week two would result in a decrease in recall for symptom frequency 
and severity scores at longer timeframes.  This hypothesis was only supported for 
two of the nine symptoms (e.g. sore throats and concentration problems) when the 
reference group was six months.  
 In order to further understand the influence of symptom stability on recall 
reliability, the present study investigated the optimal recall timeframe for 
symptoms rated as variable versus symptoms rated as stable. Results suggested 
that the optimal timeframe for variable ME/CFS symptoms differed across 
symptoms, such that, the past six months was observed as the optimal timeframe 
for five of the nine symptoms measured (e.g. sore throat, lymph node, muscle 
pain, headaches, and concentration), whereas the past month was observed to be 
optimal for reporting  PEM,  unrefreshing sleep, and memory problems. Lastly, 
the past week timeframe was found to be optimal for variable joint pain. Results 
revealed that the optimal timeframe for reliably reporting stable ME/CFS 
symptoms is highly uniform, such that all nine ME/CFS symptoms measured 
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were more reliably recalled at the six month timeframe compared to the past week 
and past month timeframes. In the absence of contextual factors (e.g. stability, 
momentary severity), recall reliability across timeframes did not differ by 
symptom type. Supplemental analyses revealed that in the absence of the 
contextual factors mentioned above, the optimal timeframe for reliably reporting 
ME/CFS symptoms appear to be six months for all but one symptom (e.g. joint 
pain), which had an optimal timeframe of one month. 
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Appendix B 
Symptom Stability Survey 
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Interviewer Script: Now I am going to ask you about the stability of your health 
symptoms.  For each symptom I say out loud, please say “yes” if you have 
experienced the symptom over the past 6 months.  
 
 
AND 
 
 
If you have experienced the symptom, please tell me whether the symptom has been 
constant  
or if it has been fluctuating and inconsistent over the past 6 months 
 
A symptom that is constant is one that occurs regularly and does not change much in 
how bad or severe it is over time.  
 
A symptom that is fluctuating and inconsistent is one that does not occur regularly 
and there is no pattern to how bad or severe it is.  
 
More Examples:  
 
A constant symptom is one that is experienced every week or every day and with the 
same intensity or severity 
 
A fluctuating symptom is one that is experienced some weeks but not others and there 
is no pattern to how often it is experienced or how bad it is experienced 
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           Table 7 
Means and Standard Deviations of Symptom Severity Scores on the SI-R 
 at Interviews 1 and 2, N=51 
  
 
 
 
 
 
 
 
 
  Interview 1 Interview 2 
Symptom Timeframe M (SD) M (SD) 
Sore Throat Now 0.75 (1.11) 0.92 (1.15) 
 Week 1.51 (1.39) 1.53 (1.46) 
 Month 1.60 (1.29) 1.51 (1.27) 
 Six Months 2.04 (1.35) 1.92 (1.43) 
Lymph Nodes Now 1.16 (1.24) 1.24 (1.45) 
 Week 1.82 (1.41) 1.63 (1.46) 
 Month 1.84 (1.43) 1.76 (1.35) 
 Six Months 6.43 (6.86) 5.45 (5.75) 
Post Exertional  Now 3.45 (1.25) 3.57 (1.25) 
Malaise (PEM) Week 3.86 (0.69) 3.94 (0.73) 
 Month 3.90 (0.64) 3.86 (0.63) 
 Six Months 4.10 (0.67) 3.90 (0.61) 
Muscle Pain Now 2.84 (1.21) 2.78 (1.22) 
 Week 3.18 (0.91) 3.06 (0.93) 
 Month 3.14 (1.08) 3.10 (0.94) 
 Six Months 3.29 (1.06) 3.10 (0.85) 
Joint Pain Now 2.20 (1.54) 2.20 (1.48) 
 Week 2.45 (1.38) 2.66 (1.33) 
 Month 2.57 (1.35) 2.57 (1.25) 
 Six Months 2.63 (1.48) 2.69 (1.29) 
Unrefreshing Sleep Now 3.78  (1.22) 3.61 (1.25) 
 Week 3.78 (0.90) 3.84 (0.92) 
 Month 3.71 (0.90) 3.61 (0.90) 
 Six Months 3.75 (1.07) 3.69 (0.99) 
Headaches Now 1.41 (1.49) 1.25 (1.47) 
 Week 2.45 (1.42) 2.47 (1.43) 
 Month 2.67 (1.28) 2.45 (1.22) 
 Six Months 2.84 (1.39) 2.78( 1.19) 
Memory Problems Now 2.31 (1.57)   2.24 (1.49) 
 Week 2.96 (0.10) 2.84 (1.24) 
 Month 2.94 (1.01) 2.84 (1.10) 
 Six Months 3.02 (1.03) 3.00 (1.15) 
Difficulty  Now 2.69 (1.17) 2.84 (1.27) 
Concentrating Week 3.29 (0.88) 3.20 (1.06) 
 Month 3.22 (0.83) 3.18 (0.91) 
 Six Months 3.37 (0.96) 3.31 (0.99) 
